On June 18th the institute spun out its first biotech firm, Draig Therapeutics, specialising in precision neuroscience, ...

Robert F. Kennedy Jr.’s plan for America’s vaccines is coming into focus, with his revamped immunization advisory panel set ...

Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...

The signings - made on Clean Air Day - mean the project now has the support of more than 23 organizations across Camden and ...

Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...

Identifying good mid cap stocks from hundreds of options is no easy feat. Luckily, we've done the hard work for you.

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

Gut‑hormone incretins (e.g., GLP‑1 agonists) are the fastest growing segment, forecast to expand at a 33.15% CAGR through ...

We should talk about a common frustrating feeling. Many people recognize this situation right away. A man explains something ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by 2035, representing a robust CAGR of 9.80%.Increasing prevalence of ...